Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: Role in response to chemoprevention and cancer development

Clinical Cancer Research

Volumn 7, Issue 10, 2001, Pages 3127-3134

  Papadimitrakopoulou, Vassiliki A ^a   Keck, Jamie ^a   Hamilton, David ^a   Dong Moon Shin, Dong ^a   Hong, Waun K ^a   Izzo, Julie ^a   Den Hollander, Petra ^a   Hittelman, Walter N ^a   Mao, Li ^a   El Naggar, Adel ^a   Liu, Diane ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA TOCOPHEROL; CYCLIN D1; ISOTRETINOIN; PROTEIN P16;

ARTICLE; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL CYCLE PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG TARGETING; DYSPLASIA; FEMALE; GENE AMPLIFICATION; HEAD AND NECK CANCER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; METHYLATION; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

ADULT; AGED; CELL CYCLE PROTEINS; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLINS; DNA; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS;

EID: 0034791377     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 1-phase progression
2. The p16INK4a/CDKN2A tumor suppressor and its relatives
3. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma
4. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression
5. Function of a human cyclin gene as an oncogene
6. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: In vivo evidence for an association with subsequent gene amplification
7. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas
8. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck
9. Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: Correlation of protein expression with lymph node metastases and advanced clinical stage
10. Overexpression of cyclin D1 indicates a poor prognosis in squamous call carcinoma of the head and neck
11. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression
12. 1 regulation in human head and neck cancer
13. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma
14. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck
15. Homozygous deletions and loss of expression of the CDKN2 gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors
16. Genetic progression model for head and neck cancer: Implications for field cancerization
17. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment
18. Frequent inactivation of p16INK4a in oral premalignant lesions
19. Cancer chemoprevention
20. 13-cis-Retinoic acid in the treatment of oral leukoplakia
21. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck
22. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients
23. Long term follow-up study of laryngeal precancer
24. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract
25. Methylation-specific, PCR: A novel PCR assay for methylation status of CpG islands
26. Posttranslational mechanisms contribute to the suppression of specific cyclin: CDK complexes by all-trans retinoic acid in human bronchial epithelial cells
27. Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation
28. Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism
29. Cyclin D1 proteolysis. A retinoid chemoprevention signal
30. Cell cycle regulation by the ubiquitin pathway
31. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
32. β-catenin regulates expression of cyclin D1 in colon
33. Immunohistochemical staining for markers of future neoplastic progression in the larynx
34. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis
35. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis
36. Rb and p16INK4a expression in resected non-small cell lung tumors
37. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: Correlation with retinoblastoma protein expression
38. Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions